These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 30241508

  • 21. Systolic blood pressure as a predictor of incident albuminuria and rapid renal function decline in type 2 diabetic patients.
    Sheen YJ, Lin JL, Li TC, Bau CT, Sheu WH.
    J Diabetes Complications; 2014; 28(6):779-84. PubMed ID: 25219331
    [Abstract] [Full Text] [Related]

  • 22. Usefulness of urinary biomarkers to estimate the interstitial fibrosis surface in diabetic nephropathy with normal kidney function.
    González J, Jatem E, Roig J, Valtierra N, Ostos E, Abó A, Santacana M, García A, Segarra A.
    Nephrol Dial Transplant; 2022 Oct 19; 37(11):2102-2110. PubMed ID: 35583251
    [Abstract] [Full Text] [Related]

  • 23. Urinary epidermal growth factor and monocyte chemotactic protein-1 as biomarkers of renal injury in patients with obstructed nephropathy.
    El-Dydamony EM, Abdelaal MA, Kasim SA, Ameen DR, El-Fattah DAA.
    Arch Ital Urol Androl; 2022 Dec 27; 94(4):443-446. PubMed ID: 36576463
    [Abstract] [Full Text] [Related]

  • 24. Association of urinary monocyte chemoattractant protein-1 (MCP-1) and kidney injury molecule-1 (KIM-1) with risk factors of diabetic kidney disease in type 2 diabetes patients.
    Siddiqui K, Joy SS, Al-Rubeaan K.
    Int Urol Nephrol; 2019 Aug 27; 51(8):1379-1386. PubMed ID: 31250339
    [Abstract] [Full Text] [Related]

  • 25. Urinary biomarkers of tubular injury to predict renal progression and end stage renal disease in type 2 diabetes mellitus with advanced nephropathy: A prospective cohort study.
    Satirapoj B, Pooluea P, Nata N, Supasyndh O.
    J Diabetes Complications; 2019 Sep 27; 33(9):675-681. PubMed ID: 31227289
    [Abstract] [Full Text] [Related]

  • 26. Urine Epidermal Growth Factor, Monocyte Chemoattractant Protein-1 or Their Ratio as Biomarkers for Interstitial Fibrosis and Tubular Atrophy in Primary Glomerulonephritis.
    Worawichawong S, Worawichawong S, Radinahamed P, Muntham D, Sathirapongsasuti N, Nongnuch A, Assanatham M, Kitiyakara C.
    Kidney Blood Press Res; 2016 Sep 27; 41(6):997-1007. PubMed ID: 27988512
    [Abstract] [Full Text] [Related]

  • 27. Low levels of urinary epidermal growth factor predict chronic kidney disease progression in children.
    Azukaitis K, Ju W, Kirchner M, Nair V, Smith M, Fang Z, Thurn-Valsassina D, Bayazit A, Niemirska A, Canpolat N, Bulut IK, Yalcinkaya F, Paripovic D, Harambat J, Cakar N, Alpay H, Lugani F, Mencarelli F, Civilibal M, Erdogan H, Gellermann J, Vidal E, Tabel Y, Gimpel C, Ertan P, Yavascan O, Melk A, Querfeld U, Wühl E, Kretzler M, Schaefer F, 4C Study, ESCAPE Trial Group.
    Kidney Int; 2019 Jul 27; 96(1):214-221. PubMed ID: 31005273
    [Abstract] [Full Text] [Related]

  • 28. Diabetic Nephropathy Can Be Treated with Calcium Dobesilate by Alleviating the Chronic Inflammatory State and Improving Endothelial Cell Function.
    Zhou Y, Qi C, Li S, Shao X, Mou S, Ni Z.
    Cell Physiol Biochem; 2018 Jul 27; 51(3):1119-1133. PubMed ID: 30476916
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Urinary epidermal growth factor excretion is correlated to renal function loss per se and not to the degree of diabetic renal failure.
    ter Meulen CG, Bilo HJ, van Kamp GJ, Gans RO, Donker AJ.
    Neth J Med; 1994 Jan 27; 44(1):12-7. PubMed ID: 8202200
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Urinary epidermal growth factor predicts renal prognosis in antineutrophil cytoplasmic antibody-associated vasculitis.
    Wu L, Li XQ, Goyal T, Eddy S, Kretzler M, Ju WJ, Chen M, Zhao MH.
    Ann Rheum Dis; 2018 Sep 27; 77(9):1339-1344. PubMed ID: 29724728
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Predicting treatment response and clinicopathological findings in lupus nephritis with urine epidermal growth factor, monocyte chemoattractant protein-1 or their ratios.
    Ngamjanyaporn P, Worawichawong S, Pisitkun P, Khiewngam K, Kantachuvesiri S, Nongnuch A, Assanatham M, Sathirapongsasuti N, Kitiyakara C.
    PLoS One; 2022 Sep 27; 17(3):e0263778. PubMed ID: 35271583
    [Abstract] [Full Text] [Related]

  • 37. ACE inhibitors improve diabetic nephropathy through suppression of renal MCP-1.
    Amann B, Tinzmann R, Angelkort B.
    Diabetes Care; 2003 Aug 27; 26(8):2421-5. PubMed ID: 12882873
    [Abstract] [Full Text] [Related]

  • 38. Serum angiopoietin-2: a promising biomarker for early diabetic kidney disease in children and adolescents with type 1 diabetes.
    Salem NA, Ismail WM, Hendawy SR, Abdelrahman AM, El-Refaey AM.
    Eur J Pediatr; 2024 Sep 27; 183(9):3853-3862. PubMed ID: 38884820
    [Abstract] [Full Text] [Related]

  • 39. Increased urinary excretion of monocyte chemoattractant protein-1 in proteinuric renal diseases.
    Morii T, Fujita H, Narita T, Koshimura J, Shimotomai T, Fujishima H, Yoshioka N, Imai H, Kakei M, Ito S.
    Ren Fail; 2003 May 27; 25(3):439-44. PubMed ID: 12803507
    [Abstract] [Full Text] [Related]

  • 40. Clinical impact of albuminuria and glomerular filtration rate on renal and cardiovascular events, and all-cause mortality in Japanese patients with type 2 diabetes.
    Wada T, Haneda M, Furuichi K, Babazono T, Yokoyama H, Iseki K, Araki S, Ninomiya T, Hara S, Suzuki Y, Iwano M, Kusano E, Moriya T, Satoh H, Nakamura H, Shimizu M, Toyama T, Hara A, Makino H, Research Group of Diabetic Nephropathy, Ministry of Health, Labour, and Welfare of Japan.
    Clin Exp Nephrol; 2014 Aug 27; 18(4):613-20. PubMed ID: 24132561
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.